Use of OB-101 to treat ocular inflammation

Thumbnail
View/Open
Date
1993-03-16
Author
Metadata
Show full item record
Abstract
A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of inflammation in both the anterior and posterior portions of the eye.
URI
http://hdl.handle.net/1969.1/177526
Subject
514/227.2
424/427
514/912
Collections
Citation
Chiou, George C. Y. (1993). Use of OB-101 to treat ocular inflammation. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from http : / /hdl .handle .net /1969 .1 /177526.